NuGen Medical Devices Inc Total Liabilities

Latest as of March 2026: CA$18.51 Million CAD ≈ $13.39 Million USD

NuGen Medical Devices Inc total liabilities. Based on the latest financial reports, NuGen Medical Devices Inc (NGMD) has total liabilities worth CA$18.51 Million CAD (≈ $13.39 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See NuGen Medical Devices Inc (NGMD) defensive interval to measure how many days the company can operate on defensive assets alone.

Total Liabilities of NuGen Medical Devices Inc (2020–2025)

Total liabilities of NuGen Medical Devices Inc from 2020 to 2025. This chart illustrates how NuGen Medical Devices Inc's total liabilities have evolved over time, based on quarterly financial data.

NuGen Medical Devices Inc Competitors by Total Liabilities

The table below lists competitors of NuGen Medical Devices Inc ranked by their total liabilities.

Company Country Total Liabilities
Williamson Magor & Company Limited
NSE:WILLAMAGOR
India Rs2.28 Billion
Nrgene Technologies Ltd
TA:NRGN
Israel ILA5.12 Million
Alpha Star Acquisition Corp
NASDAQ:ALSA
USA $2.97 Million
Imagine Lithium Inc
V:ILI
Canada CA$234.08K
Global Power Solutions Corp.
V:PWER
Canada CA$465.18K
SIGNATURE RESOURCES NEW
F:3S30
Germany €2.09 Million
Nuwellis Inc
NASDAQ:NUWE
USA $11.17 Million
Lanesborough Real Estate Investment Trust
V:LRT-UN
Canada CA$201.06 Million

Liability Composition Analysis (2020–2025)

This chart breaks down NuGen Medical Devices Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see NuGen Medical Devices Inc (NGMD) total assets.

Liquidity & Leverage Metrics

NuGen Medical Devices Inc Total Liabilities Ratios Explained

NuGen Medical Devices Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 0.70 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -1.21 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 5.82 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how NuGen Medical Devices Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for NuGen Medical Devices Inc (2020–2025)

The table below shows the annual total liabilities of NuGen Medical Devices Inc from 2020 to 2025.

Year Total Liabilities Change
2025-12-31 CA$18.03 Million
≈ $13.04 Million
-2.90%
2024-12-31 CA$18.57 Million
≈ $13.43 Million
+106.15%
2023-12-31 CA$9.01 Million
≈ $6.51 Million
-1.16%
2022-12-31 CA$9.11 Million
≈ $6.59 Million
+26.78%
2021-12-31 CA$7.19 Million
≈ $5.20 Million
-52.88%
2020-12-31 CA$15.25 Million
≈ $11.03 Million
--

About NuGen Medical Devices Inc

V:NGMD Canada Medical Devices
Market Cap
$2.46 Million
CA$3.41 Million CAD
Market Cap Rank
#29772 Global
#1417 in Canada
Share Price
CA$0.02
Change (1 day)
-25.00%
52-Week Range
CA$0.02 - CA$0.05
All Time High
CA$0.45
About

NuGen Medical Devices Inc., a specialty medical device company, engages in developing and commercializing novel drug delivery technologies in Europe, Asia, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, vaccines, veterinary, home healthcare, and others. It also provides Ins… Read more